| 現職： | – 中山醫學大學校長 – 中山醫學大學教授 – 中山醫學大學附設醫院內分泌新陳代謝科主治醫師 – 糖尿病學會理事長 |
| 專長： | 糖尿病及其慢性併發症、甲狀腺疾病及其他內分泌疾病、肥胖、骨質疏鬆症、男女性更年期 |
| 過去五年內執行臨床試驗案件數： | 10 件以上 |
| 近五年論文著作： | 《2025》王威傑、黃建寧(通訊作者) Frontiers in pharmacology 2025 Oct 20:16:1686851 Comparative cardiovascular risks of canagliflozin and selective SGLT2 inhibitors in type 2 diabetes 《2025》Chih-Wei Chiang、黃建寧(通訊作者)、廖勇柏(通訊作者) International journal of medical sciences 2025 Sep 22;22(15):4077-4084 Exploring the relationship between exercise and diabetes risk in a prediabetes population 《2025》Chiung-Huei Peng、黃建寧(通訊作者)、李彗禎(通訊作者) Antioxidants 2025 Aug 4;14(8):955 Abelmoschus esculentus Ameliorates Cognitive Impairment in Hyperlipidemic ApoE-/- Mice via Modulation of Oxidative Stress and Neuronal Differentiation 《2025》張世宗、黃建寧(通訊作者)、廖勇柏(通訊作者) Journal of diabetes research 2025 May 27:2025:5531934 Type 2 Diabetes in Taiwan: Unmasking Influential Factors Through Advanced Predictive Modeling 《2025》鄒欣樺、Chien-Yin Kuo、王威傑、黃建寧(通訊作者)、Chih-Li Lin(通訊作者) Cellular and molecular life sciences 2025 Jan 8;82(1):39 The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy 《2023》黃建寧、Chiung-Huei Peng Journal of medicinal food 2023 Jul;26(7):462-469 Abelmoschus esculentus (Okra) Prevents Insulin Resistance and Restores Neuron Autophagy by Regulating Dipeptidyl Peptidase-4 and Thus Improving Hippocampal Function 《2023》羅仕昌、楊宜瑱(通訊作者)、黃建寧(通訊作者) Diabetes research and clinical practice 2023 Jun;200:110685 Pioglitazone, SGLT2 inhibitors and their combination for primary prevention of cardiovascular disease and heart failure in type 2 diabetes: Real-world evidence from a nationwide cohort database 《2023》林聖傑、Sing-Hua Tsou、Chih-Li Lin(通訊作者)、黃建寧(通訊作者) International journal of molecular sciences 2023 Jun 17;24(12):10289 Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals 《2022》吳月珠、黃建寧(通訊作者) 健康科技期刊 2022;9(1):12-27 Using a Food Monopoly-style Game to Improve Blood Glucose Control in Patients with Type 2 Diabetes 《2022》Edy Kornelius、S.H Tsou、黃建寧(通訊作者)、C.L. Lin(通訊作者) Biomolecules 2022 Sep 21;12(10):1338 Liraglutide Attenuates Glucolipotoxicity-Induced RSC96 Schwann Cells’ Inflammation and Dysfunction 《2022》Chia-Hung Lin、Chii-Min Hwu(通訊作者)、黃建寧(通訊作者) Journal of the Chinese Medical Association 2022 Jul 1;85(7):741-746 Use of expert consensus to improve the diagnosis and management of type 1 diabetes mellitus 《2022》周英香、黃建寧(通訊作者)、Y.P. Liaw(通訊作者) PloS one 2022 May 5;17(5):e0267387 Effects of aerobic and resistance exerci glycosylated hemoglobin (HbA1c) concentrations in non-diabetic Taiwanese individuals based on the waist-hip ratio 《2022》C.H. Peng、黃建寧(通訊作者)、C.L. Lin(通訊作者) PloS one 2022 Mar 15;17(3):e0265444 Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4 With improving insulin resistance |